Skip To Main Content
Robert O'Neill on Muck Rack

Robert O'Neill

As seen in: The Late Night Grin, MSN, MSN Australia, MSN India, MSN Ireland, MSN New Zealand, MSN Singapore, MSN Malaysia, MSN Philippines, MSN South Africa, The Daily Mirror and
@LateNightGrin. Probably doing a bit. Gainfully employed.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB‐fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency

|
By Lukáš Homola, Isaac P. Thomsen, Piotr Korbal, Elizabeth Wang, Yanping Liu, Robert O'Neill, Jason Maguire, Paula Peyrani, Annaliesa S. Anderson, Johannes Beeslaar, Piotr Korbal, Ashlesh Murthy, Beth Moughan
| Wiley Online Library Verified
To the Editor, Invasive meningococcal disease (IMD) is a life-threatening disease caused by Neisseria meningitidis infection [1]. Meningococcal serogroup B (MenB) is the predominant disease-causing serogroup in numerous regions, including the United States and Europe [1]. The MenB-fHbp (Trumenba [bivalent rLP2086]; Pfizer Inc., Philadelphia, PA, USA) MenB vaccine is composed of two lipidated factor H binding protein (fHbp) variants from subfamily A and subfamily B [2].
Open in Who Shared Issue with article?

Ecology & Society: Volume 4, Issue 2

|
By C. S. Holling, Kurt Riitters, James Wickham Verified, Robert O'Neill
| Ecology and Society Verified
Skip to content Opens in a new window Opens an external site Opens an external site in a new window Response Reasoning without Data, Default Assumptions A response to: Walker and Lonsdale. 2000. "Genetically Modified Organisms at the Crossroads: Comments on "Genetically Modified Crops: Risks and Promise" by Gordon Conway" Suspect Visions A response to: Kotyk. 1999. "No Vision = Wandering in the Wilderness" God, Nature, and Interpretation A response to: Rogers, Roux and Biggs. 2000.
Open in Who Shared Issue with article?

Severe dengue fever with secondary haemophagocytic lymphohistiocytosis

|
By Robert O'Neill, Simran Dhugga, Harry Crane
| Wiley Online Library Verified
John Moore St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia Blood, Stem Cells and Cancer Research Laboratory, St Vincent's Centre for Applied Medical Research, Sydney, New South Wales, Australia Search for more papers by this author
Open in Who Shared Issue with article?
See all 1,064 licensed articles (1,067 Total)